E-resources
-
Aarsetøy, Reidun; Ueland, Thor; Aukrust, Pål; Michelsen, Annika E.; Fuente, Ricardo Leon; Pönitz, Volker; Brügger‐Andersen, Trygve; Grundt, Heidi; Staines, Harry; Nilsen, Dennis W.T.
Journal of internal medicine, October 2021, 2021-10-00, 20211001, Volume: 290, Issue: 4Journal Article
Background Plasma levels of angiopoietin‐2 (ANGPT2) and angiopoietin‐like 4 protein (ANGPTL4) reflect different pathophysiological aspects of cardiovascular disease. We evaluated their association with outcome in a hospitalized Norwegian patient cohort (n = 871) with suspected acute coronary syndrome (ACS) and validated our results in a similar Argentinean cohort (n = 982). Methods A cox regression model, adjusting for traditional cardiovascular risk factors, was fitted for ANGPT2 and ANGPTL4, respectively, with all‐cause mortality and cardiac death within 24 months and all‐cause mortality within 60 months as the dependent variables. Results At 24 months follow‐up, 138 (15.8%) of the Norwegian and 119 (12.1%) of the Argentinian cohort had died, of which 86 and 66 deaths, respectively, were classified as cardiac. At 60 months, a total of 259 (29.7%) and 173 (17.6%) patients, respectively, had died. ANGPT2 was independently associated with all‐cause mortality in both cohorts at 24 months hazard ratio (HR) 1.27 (95% confidence interval (CI), 1.08–1.50) for Norway, and HR 1.57 (95% CI, 1.27–1.95) for Argentina, with similar results at 60 months HR 1.19 (95% CI, 1.05–1.35) (Norway), and HR 1.56 (95% CI, 1.30–1.88) (Argentina), and was also significantly associated with cardiac death HR 1.51 (95% CI, 1.14–2.00), in the Argentinean population. ANGPTL4 was significantly associated with all‐cause mortality in the Argentinean cohort at 24 months HR 1.39 (95% CI, 1.15–1.68) and at 60 months HR 1.43 (95% CI, 1.23–1.67), enforcing trends in the Norwegian population. Conclusions ANGPT2 and ANGPTL4 were significantly associated with outcome in similar ACS patient cohorts recruited on two continents. Clinical Trial Registration ClinicalTrials.gov Identifier: NCT00521976. ClinicalTrials.gov Identifier: NCT01377402.
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.